TABLE 2.
Variables affecting the patients' outcome
| Variable | Pneumothorax | Pneumothorax+ Pneumomediastinum | Pneumomediastinum | P value | |
|---|---|---|---|---|---|
| 22(51.2%) | 11(25.6%) | 10(23.3%) | |||
| Gender | Male | 22(52.4%) | 11(26.2%) | 9(21.4%) | .11 |
| Female | 0(0.0%) | 0(0.0%) | 1(3.4%) | ||
| Blood groups | A+ | 9(52.9%) | 6(35.3%) | 2(11.8%) | .34 |
| A− | 0(0.0%) | 1(100%) | 0(0.0%) | ||
| B+ | 5(45.5%) | 2(18.2%) | 4(36.4%) | ||
| B− | 2(66.7%) | 1(33.3%) | 0(0.0%) | ||
| O+ | 6(60.0%) | 1(10.0%) | 3(30.0%) | ||
| O− | 0(0.0%) | 0(0.0%) | 1(100%) | ||
| SOFA * score | <6 | 22(59.5%) | 9(24.3%) | 6(16.2%) | .03 a |
| 7 to 12 | 0(0.0%) | 2 (40.0%) | 3(60.0%) | ||
| >12 | 0(0.0%) | 0(0.0%) | 1(100%) | ||
| Comorbidities | DM | 7(53.8%) | 3(23.1%) | 3(23.1%) | .9 |
| HTN | 4(40.0%) | 2(20.0%) | 4(40.0%) | .3 | |
| CAD | 1(50.0%) | 1(50.0%) | 0(0.0%) | .6 | |
| CKD | 2(40.0%) | 2(40.0%) | 1(20.0%) | .7 | |
| CRI | 2 (50.0%) | 1(25.0%) | 1(25.0%) (25.0%) | .9 | |
| Hyper | 2(66.7%) | 1(33.3%) | 0(0.0%) | .4 | |
| CLD | 1(100%) | 0(0.0%) | 0(0.0%) | ||
| Chest drain | 18(62.1%) | 11(37.9%) | 0(0.0%) | .001 a | |
| Intubation | 19(48.7%) | 11(28.2%) | 9(23.1%) | .4 | |
| P/F ratio | <150 | 19(44.18%) | 8(18.60%) | 8(18.60%) | .7 |
| >150 | 3(37.5%) | 3(37.5%) | 2(25.0%) | ||
| NIV | 14(51.9%) | 7(25.9%) | 6(22.2%) | .9 | |
| HFNC | 6(50.0%) | 4(33.3%) | 2(16.7%) | .7 | |
| Prone position | 16(47.1%) | 10(29.4%) | 8(23.5%) | .4 | |
| PEEP | None | 3(100%) | 0(0.0%) | 0(0.0%) | .4 |
| ≤10 | 11(44.0%) | 7(28.0%) | 7(28.0%) | ||
| >10 | 8(53.3%) | 4(26.7%) | 3(20.0%) | ||
| Compliance (mL/cm H2O) | ≥40 | 3(100%) | 0(0.0%) | 0(0.0%) | .05 a |
| >25 | 2(33.3%) | 4(66.7%) | 0(0.0%) | ||
| ≤25 | 17(50.0%) | 7(20.6%) | 10(29.4%) | ||
| Mortality | 10(45.5%) | 7(31.8%) | 5(22.7%) | .61 | |
a
Sequential organ failure Assessment score.
Abbreviations: CAD, coronary artery disease; CKD, chronic kidney disease; CLD, chronic liver disease; CRI, chronic respiratory illness; DM, diabetes mellitus; HFNC, high flow nasal cannula; HTN, hypertension; NIV, noninvasive ventilation; PEEP, positive end expiratory pressure/cmH20.